Stress Management and Resiliency Training Program for Parkinson's Disease
Trial
N/A
Completed
April 27, 2026
Effectiveness of Virtual Reality in Parkinson's Disease: Effects on Balance, Fall Risk, and Exercise Capacity.
Trial
N/A
Not yet recruiting
April 27, 2026
Selective vulnerability of monoaminergic neurons and network spread of alpha-synuclein jointly explain pathology progression in Parkinson's disease models.
Research
Neurobiology of disease
April 27, 2026
Barriers and enablers to cognitive assessment in Parkinson's disease: A qualitative contextual inquiry
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
April 26, 2026
Effects of Blood Pressure on Cognition and Cerebral Hemodynamics in PD
Trial
N/A
Withdrawn
April 26, 2026
Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease
Trial
N/A
Not yet recruiting
April 26, 2026
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease
Trial
N/A
Active, not recruiting
April 26, 2026
Self-administered tDCS for Improving Single- and Dual-task Gait in Patients With PD
Trial
N/A
Completed
April 26, 2026
Evaluation of the Effects of Levodopa-Benserazide Drug Combination on Periodontal Status in Patients With Parkinson's Disease
Trial
N/A
Active, not recruiting
April 26, 2026
April Awe Walk, 2026
News
Parking Suns
April 24, 2026
“ChatGPT knows my Parkinson's”: Perspectives of people with Parkinson's disease on use of generative AI
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
April 23, 2026
Comment on “The impact of diet on Parkinson's disease risk: A data-driven analysis in a large Italian case-control population”
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
April 23, 2026
Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease
Trial
N/A
Active, not recruiting
April 23, 2026
Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease 2
Trial
N/A
Active, not recruiting
April 23, 2026
Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders
Trial
N/A
Enrolling by invitation
April 23, 2026
Hereditary Parkinson s Disease Natural History Protocol
Trial
N/A
Completed
April 23, 2026
Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus
Trial
Early Phase 1
Not yet recruiting
April 23, 2026
Glycolysis as a central pathological axis in neurodegenerative diseases.
Research
Reviews in the neurosciences
April 23, 2026
A framework of digital biomarkers for neurodegenerative diseases.
Research
Nature reviews bioengineering
April 23, 2026